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It  is known that diphtheria antitoxin  is associated in horse serum
with  its pseudoglobulin  constituent.  For  therapeutic  purposes  this
protein fraction  has been extracted  from  the whole  serum,  thus  ob-
taining a purer, or refined  antitoxin preparation.  It  seemed  possible
that the same  principle  might  be applied  to the  coagulative  factor
in  serum,  and  that in  this  respect  the  active  substance  might like-
wise be linked with one protein  fraction  rather  than with the serum
as  a  whole.  Horse  serum  is  extensively  used  for  hemostatic  pur-
poses,  and  if  the coagulative  principle  could  be  separated,  it might
lead to the preparation of a refined hemostatic as potent as the origi-
nal  serum  and  containing  a  greatly  diminished  amount  of protein.
With  this  end  in  view,  the  albumin,  the  pseudoglobulin,  and  the
euglobulin were separated by means of ammonium sulphate of various
strengths  and  were  tested  for  their  coagulative  efficiency.  A  brief
report  of  this  work  was  made  some  months  ago.'  Although  this
process  does  not yield protein  fractions  of absolute  purity, it is the
best method for the purpose, affording  a sharp demarcation  between
the  group  of  albumins  and  globulins,  and  a  fairly  sharp  division
between  the  soluble  pseudoglobulin  and  the  less soluble  euglobulin.
The method  followed  was  the  one used  in this laboratory  for  the
preparation  of  refined  diphtheria  antitoxin.  It  consists  of  diluting
the serum with one-half of its volume of water, and then precipitating
the euglobulinwith a 30 per cent ammonium sulphate solution; a small
amount  of pseudoglobulin  comes  down  in the  course  of  the process.
The  ammonium  salt is  then  added up  to 54 per  cent  to carry down
'Hess,  A.  F.,  Proc. Soc.  Exp.  Biol. and Med.,  1916,  xiii,  125.
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the  pseudoglobulin,  after  which  enough  is  added  to  the  filtrate  to
precipitate  all the albumin.2
TABLE  I.
The  Coagulative Effect of Adding the Protein  Fractions of Human Serum to Normal
Human Blood.
Control  Euglobulin.  Albumin.  Pseudoglobulin.
blood.  - Time.
1 drop.  2 drops.  I drop.  2 drops.  1 drop.  2 drops.
mil$.
+  +  +  +  +  +  +  4
+  +  ++  ++  + +  ++  ++  8
+  +++  +++  +  ++  +++  ++  ++  ++  ++  10
+  ++  +  ++  ++  ++  12
+++  I  I  I  ++  +  +++  +++  15
+++  +++  18
Tests with  Human Serum.
The  nature  of  the  tests  and  their  results are  shown in the tables.
For the test illustrated in Table I, the fractions  were prepared  from
human  serum.  It  was  determined  in  the  course  of later  tests  that
the fractions  had apparently identical action  whether prepared  from
human,  from  horse,  or from  sheep  serum;  accordingly  horse  serum
was  used as it was  most available.  In  view of the fact  that it had
been  found  that  antitoxin  is  associated  with  the pseudoglobulin  in
the  horse,  but  with  the  globulin  in  the  serum  of  the  goat,  it was
deemed  advisable  to  carry  out  the  preliminary  tests  upon  human
as well  as  upon  animal  sera.'  It  will be  noted  from Table I that
the addition of one or two drops of euglobulin hastened coagulation,
whereas the same amount of the other proteins failed  to bring about
this result.  This was  the usual course of all experiments  of this kind,
although  in  some  instances  the  differences  did  not  stand  out  so
sharply.
2  These separations  were carried out by Mr.  Edward  Banzhof.
a Steinhardt, E., and Banzhof, E., unpublished work  of the  Research  Labora-
tory  of the  Department  of Health,  New York.
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TABLE  II.
The  Coagulative Effect of  Adding the  Protein Fractions of Human Serum  to  the
Blood and Plasma of Hemophiliacs.
(A)  Case 1.  Blood.
Control  Euglobulin.  Seroalbumin.  Pseudoglobulin.  Time
blood.
1 drop.  2 drops.  1 drop.  2 drops.  I  drop.  2 drops.
"sin.
- --  ---  4
+  +  +  8
++  ++  +  +  +  12
++  ++  ++  +  +  +  +  14
++  ++  ++  ++  ++  ++  ++  18
+  +++  +++  ++  ++  ++  ++  20
++  ++  ++  ++  ++  24
++  ++  ++  ++  ++  28
++  +++  +++  ++  ++  34
++  . . . ++  +++  36
__+++  __  _  _  I  ++  42
(B)  Case 2.  Plasma.
+  ++  _  - _  8
+  +  +  +  +  ++  +  10
+  ++  +  +  ++  +  12
+  +++  +  ++  ++  ++  14
+  ++  +++  ++  ++  16
++  +++  +++  +++  18
+++  . . I  I26
Table II  illustrates a similar test carried out in a case of hereditary
hemophilia,  where  the  blood  had a  coagulation  time  of  42 minutes
and  the plasma  of  26  minutes.4 Here  again  the  euglobulin  caused
a  marked  shortening  of  the  coagulation  time,  whereas  the  other
fractions produced  this  effect  to a less  degree.
When  it  was  not  desired  to  obtain  the  three  protein  fractions
separately  but only  to  precipitate  the  euglobulin  from  the  serum,
4 For  the  coagulation  tests  of  blood  a  simple  method  suggested  by  Howel
(Arch. Int. Med.,  1914,  xiii,  76)  was  employed.  The  basilic  vein  was  punctured
and  15 drops  of blood were  allowed  to  flow  from  the needle into  a vial  having
a diameter  of 1.5  cm.  When the  vial  could  be  inverted without  spilling any of
its contents,  coagulation  was  considered  to be complete.
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sodium chloride was  employed instead  of ammonium sulphate,  as the
former  process is simpler  and was  found to give  an equally effective
product.  The method  pursued was  as follows:  The serum was  satu-
rated  in  the cold  with  chemically  pure  crystals  of  sodium  chloride.
It  was then filtered,  and a  small amount  of chloroform  added  to the
precipitate,  which  was  dialyzed  for  about  a  week.  The  dialysate
was  taken  up with  Ringer's  solution,  and  0.3  per  cent  of  tricresol
added.  This was then filtered  through a Berkefeld filter and bottled
in 20  cc.  vials.
The percentage  of total solids,  which may be regarded as euglobu-
lin,  varied in the  different  lots prepared,  so  that an  estimation  was
made in every instance.  In the lot used in the test shown  in Table
III, there was 2.5 per cent euglobulin, in another the percentage might
TABLE  III.
The Action of Different  Concentrations of Euglobulin on Purpuric  and on Normal
Plasma.
Purpuric  Plasma.
Euglobulin.
Control plasma.  Time.
1.25 per cent, 1 drop.  2.5 per cent,  1  drop.
min
+  +  +  4
+  ++  ++  8
++  +++  +++  10
++  14
++  18
++  22
-i--+  26
Normal Plasma.
Euglobulin.
Control plasma.  1.25 per cent.  2.5 per cent.  Time.
I drop.  2 drops.  1  drop.  2 drops.
min.
+  +  +  +  ++  4
+  +  +  +++  ++  +++  6
++  +++  8
++_+  lO
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be over 3 per cent,  in which event it was  diluted with Ringer's solu-
tion to 2 per  cent.  This test  (Table III) shows that when we reach
a  certain  maximum,  the  addition  of  a  large  amount  of  euglobulin
ceases  to have  any further effect;  that, for  example,  the coagulation
time  may  remain  the  same  whether  we  add  a  drop  of a  1.25  per
cent solution or of a 2.5 per  cent solution of euglobulin to five  drops
of plasma.  In another test (Table IV) made with a different prepa-
ration  we note  that two drops  are more effective  than one, but that
we have then reached  the optimal strength,  and that three  drops  of
TABLE  IV.
The  Comparative Activity  of Whole Serum and Euglobulin on Human Plasma.
Control  Whole serum.  Euglobulin,  2 per cent.
plasma.  Time.
drop.  2  drops.  3 drops.  I drop.  2 drops.  3 drops.
min.
- . - ..  +  +  4
- - +  +  +  +  6
+  +  +  +  ++  +  8
+  +  +  +  +  ++  ++  10
+  +  +  +  +  +  +  +++  +++  12
+  +  ++  +  ++  16
++  +±  +++  +++  20
+++  +++  22
euglobulin  fail  to heighten the effect.  Table III likewise  illustrates
the fact  that the euglobulin  is able to hasten the  clotting of plasma
in  purpura,  another  type of  hemorrhagic  disease.  In  this  instance
the blood  was  from  a case  of purpura  showing  all the  usual  symp-
toms-a  slightly  delayed  coagulation  time,  a  markedly  diminished
platelet count, a  prolonged  bleeding  time,  and  a  positive  capillary
resistance test.
Mode of  Action  of Euglobulin.
There  are  many  ways  in  which  substances  exert  a  coagulative
effect  upon  the  blood.  Without  entering  in  detail  upon  this  sub-
ject,  it  may  be  stated  that  we  may  divide  these  acceleratory  sub-
stances  into  two groups;  those  which  act by neutralizing  inhibiting
substances,  and those  which possess  inherent activity in themselves.
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To which class does euglobulin belong?  The  answer to this question
can best be given by comparing  the euglobulin to a substance which
is known  to derive its potency through overcoming the antithrombin
of  the blood.  An experiment  of this kind is reproduced  in Table  V,
where the  effect  of  tissue juice is  compared  with  that of  euglobulin.
TABLE  V.
Comparison between the Neutralizing Power of Euglobulin and of a Thromboplastic
Solution when Rirudin Was Added to Plasma.
(A)  Titration of Euglobulin and Thromboplastin Solution to Equal Strengths.
Euglobulin.  Thromboplastin,
Control  1 drop.
plasma.  ITime
I  drop.  2 drops.  1:1,250  1: 2,500  1:5,000
win
+  +  +++  ++  ++  +  2
++  +++  +++  +++  ++  3
++  +++  4
~~~~~~~~~~+++  ~~~6
(B)  Relative Coagulative Potency of  the Solutions when Hirudin Was  Added.
Euglobulin,  Thromboplastin,
Plasma + hirudin.  drop + hirudin.  I  2,500 + hiudin  Time.
min.
--  - ++  4
+  +  +++  6
+  +  8
+  +  10
+  ++  35
+  +++  42
++  120
+++  130
* Hirudin  in  these  tests  refers  to  a  1: 5,000  solution.  This  strength  was
found  optimal  for  this  experiment.
It  has long  been  known that  the various  tissue juices  of the  body,
those of the muscles,  of the brain,  of  the glandular organs,  etc.,  are
powerful  coagulants.  It  has also been  established  that they possess
this  power  in  virtue  of  being  able  to  counteract  the  normal  anti-
thrombin  of the  blood.  In this test thromboplastin  was employed,
which  consists  of  a  solution  and  suspension  of brain,  and  has been
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described  elsewhere5 as possessing marked  coagulative power both in
vitro  and  in its  clinical  application.  In the  first  part  of  this  table
we see what might be termed a state of equilibrium between the  two
coagulants,  a parallel  test in which  one  drop  of euglobulin and  one
drop  of a  dilution  of  thromboplastin  (1:  2,500)  hasten  coagulation
to the  same  degree.  When,  however,  an antithrombic  substance,  a
dilute solution of hirudin, is also added  to the plasma,  we note (Table
V) a marked difference in action.  The tissue juice almost completely
neutralizes  the  hirudin,  whereas  the  euglobulin  is  able  only partly
to overcome  its inhibitory  effect.  It  is  evident therefore  that these
substances  act  in different  ways,  and  that the  euglobulin  does not
owe its power to a counteraction  of the antithrombin.  It  is impossi-
ble to proceed further in this discussion,  and to state the exact  mode
of action of euglobulin, as so many factors remain unknown  as to the
mechanism  of coagulation.  It  would  seem,  however,  in view  of the
fact  that  euglobulin  is  found  in  the  normal  blood,  that  it  should
be  regarded  as  a  physiologic  coagulant,  and  its mode  of  action  in
these  tests as  merely  an intensification  of  the  normal clotting proc-
esses.  In this connection  we may add that this coagulative property
is  not  common  to  globulins  in  general.  For  example,  egg  globulin
showed  no  coagulative  power  (Table  VI);  and  edestin,  a vegetable
TABLE  VI.
The  Comparative Effect  of Ovoglobulin and Ovoalbumin  when Added  to the Blood
of a Hemophiliac.
Euglobulin.  Seroalbumnin.  Ovoglobulin.  Ovoalbumin.
Control blood.  Time.
I drop.  1  drop.  I drop.  I drop.
min.
+  ++  - +  - 4
+  ++  - +  - 6
++  ++  - +  - 10
++  ++  +  +  - 14
++  ++  +  +  - 16
++  +  +  +  18
++  +  ++  ++  20
+++  ++  ++  ++  30
+++  ++  ++  38
+++  +++  52
5 Hess, J.  Am.  Med. Assn.,  1915,  lxiv,  1395.
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globulin,  when  tested in various  concentrations  was found  also to be
completely  devoid  of  activity.  These  negative  results  with  ovo-
globulin  furthermore  give  evidence  that  the  more  rapid  clotting,
brought  about by  euglobulin,  cannot be  attributed  to an increase  in
viscosity.
SUMMARY  AND  CONCLUSIONS.
The  fact  that  the  coagulative  principle  is  closely associated  with
the  euglobulin fraction  of the  blood is  of  clinical as well  as of  theo-
retical  interest.  It  enables  us  to  prepare  a  hemostatic  containing
about 2 per cent of protein which is more potent than the whole serum
containing  6  to  7 per  cent  of  protein.  A preparation  of  this kind
has  been  made  in  this  laboratory  from  horse  serum  and employed
during  the  past  few  months  in  numerous  cases  of  bleeding.  This
euglobulin  is  absolutely  sterile,  as  it  has  been  passed  through  a
Berkefeld  filter,  and  is  safeguarded  against  decomposition  by  the
addition  of  0.3 per  cent tricresol.  A  detailed  account  of the thera-
peutic use of euglobulin will be reported elsewhere.  It may be stated,
however,  that it has been employed  in the various  manifestations  of
intractable  hemorrhage  in  which  horse  serum  has  been  so  largely
resorted to of late years, and that in certain cases has seemed to bring
about most  satisfactory  results;  in  no instance  has  there  been  any
untoward  effect.  When  intravenous  injections  are  resorted  to,  eu-
globulin  seems  to be preferable  to serum  which contains  fully  three
times  the quantity  of  protein.6 It  also  seems  to be  absorbed  more
quickly  from  the  subcutaneous  tissues.  In  all  probability  it  will
be found to meet the same indications as whole serum,  possessing the
advantages  of  concentration,  and necessitating  the introduction into
the body  of a much smaller  amount of  foreign protein.
6 Refined diphtheria  antitoxin is frequently used as a hemostatic when normal
serum cannot be obtained.  As this serum contains about  16 per cent  of protein,
which  consists  almost  entirely  of  pseudoglobulin,  it  will  readily  be  appreciated
that it is not adapted  to this use.
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